Table 2.
Epidemiological profiles and clinical features of 14 patients with chronic serotonin syndrome
|
Parameters
|
n
(%)
|
| Age in yr, mean ± SD | 44.1 ± 11.6 |
| Sex, M:F | 9:5 (1.8:1) |
| Duration of illness in wk | 13.5 ± 5.8 |
| Clinical characteristics | |
| Tremor | 14 (100) |
| Hyperreflexia | 14 (100) |
| Clonus | 13 (93) |
| Spasticity-rigidity | 11 (79) |
| Tachycardia | 9 (64) |
| Generalized pain | 7 (50) |
| Insomnia | 7 (50) |
| Irritability-restlessness | 7 (50) |
| Stiffness | 6 (43) |
| Diaphoresis | 6 (43) |
| Gait disturbances | 5 (36) |
| Bowel disturbances | 5 (36) |
| Dizziness | 4 (29) |
| Sexual dysfunctions | 3 (21) |
| Nystagmus | 3 (21) |
| Hypertension | 2 (14) |
| Incoordination | 2 (14) |
| Fatigue | 2 (14) |
| Fulfilments of SS criteria | |
| Hunter criteria | 14 (100) |
| Sternbach’s criteria | 11 (78) |
| Serotonergic agents implicated in 14 cases | |
| Amitriptyline | 6 (43) |
| Tramadol | 5 (36) |
| Valproate | 5 (36) |
| Paroxetine | 2 (14) |
| Sertraline | 2 (14) |
| Citalopram | 1 (7) |
| Fluoxetine | 1 (7) |
F: Female; M: Male; SD: Standard deviation; SS: Serotonin syndrome.